New Exclusive Commercialization Agreements in South Korea, Canada, and IsraelSubmission of Marketing Authorization Application for PF708 in Saudi ArabiaPotential approval […]
Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and […]